The structural modification developed in this work by the introduction of the heterocycle 1,2,4-triazole on the chalcones scaffold structure has identified lead compounds that exhibit promising anti-proliferative properties as tubulin targeting agents and aromatase inhibitors, which have potential application in the treatment of BC. Here, CYP19A1 is linked to breast cancer.